Clinical Trials Browser

Phase 1 × Withdrawn × Astrocytoma × Clear all

NCT05341947 2025-10-22

Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma

Phase 1 Withdrawn

CNS

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma

NCT01861990 2015-05-22

Valproic Acid in Childhood Progressive Brain Tumors

Phase 1 Withdrawn

CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Neuroectodermal Tumors, Primitive

NCT00458744 2014-08-08

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Phase 1 Withdrawn

CNSLymphoidOther hematologic neoplasmSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Leukemia, Lymphoma, Medulloblastoma, Recurrence, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

NCT02055196 2014-06-02

Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Phase 1 Withdrawn

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Gliosarcoma

NCT00734864 2012-11-21

Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma

Phase 1 Withdrawn

CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma